{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:31:17Z","timestamp":1788993077140,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005802","name":"Romanian National Authority for Scientific Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004616","name":"CNCS\/CCCDI-UEFISCDI","doi-asserted-by":"publisher","award":["PN-III-P1-1.1-PD-2016-1072"],"award-info":[{"award-number":["PN-III-P1-1.1-PD-2016-1072"]}],"id":[{"id":"10.13039\/501100004616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004616","name":"CNCS\/CCCDI-UEFISCDI","doi-asserted-by":"publisher","award":["PN-III-ID_PCE_2016-0921"],"award-info":[{"award-number":["PN-III-ID_PCE_2016-0921"]}],"id":[{"id":"10.13039\/501100004616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004616","name":"CNCS\/CCCDI-UEFISCDI","doi-asserted-by":"publisher","award":["179\/2017"],"award-info":[{"award-number":["179\/2017"]}],"id":[{"id":"10.13039\/501100004616","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.micpath.2019.02.012","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T17:47:28Z","timestamp":1549820848000},"page":"250-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["In vitro antimicrobial efficacy of laser exposed chlorpromazine against Gram-positive bacteria in planktonic and biofilm growth state"],"prefix":"10.1016","volume":"129","author":[{"given":"Tatiana","family":"Tozar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viorel","family":"Nastasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Stoicu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6098-1857","authenticated-orcid":false,"given":"Mariana Carmen","family":"Chifiriuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Popa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crina","family":"Kamerzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihail Lucian","family":"Pascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2019.02.012_bib1","series-title":"Antibiotic-resistant Bacteria","author":"Guilfoile","year":"2007"},{"key":"10.1016\/j.micpath.2019.02.012_bib2","unstructured":"Burden of antibiotic resistance, ReAct, (n.d.). http:\/\/www.reactgroup.org\/toolbox\/measure\/access-existing-data\/burden-of-antibiotic-resistance\/."},{"key":"10.1016\/j.micpath.2019.02.012_bib3","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/jac\/dkr260","article-title":"Effective antibacterials: at what cost? The economics of antibacterial resistance and its control","volume":"66","author":"White","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2019.02.012_bib4","unstructured":"World Economic Forum \u2013 Global Risks 2013 eighth ed., Glob. Risks 2013, (n.d.). http:\/\/wef.ch\/GJKqei."},{"key":"10.1016\/j.micpath.2019.02.012_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bcp.2016.11.002","article-title":"New approaches to antimicrobial discovery","volume":"134","author":"Lewis","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.micpath.2019.02.012_bib6","first-page":"85","article-title":"Innate and induced resistance mechanisms of bacterial biofilms","volume":"322","author":"Anderson","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.micpath.2019.02.012_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.01333","article-title":"Anti-biofilm activities from marine cold adapted bacteria against staphylococci and Pseudomonas aeruginosa","volume":"6","author":"Papa","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2019.02.012_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1465-0691.2004.1007.x","article-title":"Antimicrobial drug development \u2013 the past, the present, and the future","volume":"10","author":"Powers","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2019.02.012_bib9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2165\/11534440-000000000-00000","article-title":"New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin","volume":"70","author":"Zhanel","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.micpath.2019.02.012_bib10","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/AAC.44.12.3408-3413.2000","article-title":"Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections","volume":"44","author":"Stevens","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2019.02.012_bib11","unstructured":"FDA Approved Drugs in Infections and Infectious Diseases, CenterWatch, (n.d.). http:\/\/www.centerwatch.com\/drug-information\/fda-approved-drugs\/therapeutic-area\/25\/infections-and-infectious-diseases."},{"key":"10.1016\/j.micpath.2019.02.012_bib12","doi-asserted-by":"crossref","first-page":"iii11","DOI":"10.1093\/jac\/dkr095","article-title":"Ceftaroline fosamil: a new broad-spectrum cephalosporin","volume":"66","author":"Laudano","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2019.02.012_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jac\/dkt302","article-title":"In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin","volume":"69","author":"Leeds","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2019.02.012_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/cid\/cix182","article-title":"Ceftolozane-tazobactam for the treatment of multidrug-resistant Pseudomonas aeruginosa infections: clinical effectiveness and evolution of resistance","volume":"65","author":"Haidar","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2019.02.012_bib15","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1128\/AAC.01165-15","article-title":"First report of ceftazidime-avibactam resistance in a KPC-3-Expressing Klebsiella pneumoniae isolate","volume":"59","author":"Humphries","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2019.02.012_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.apsb.2016.06.004","article-title":"A review of global initiatives to fight antibiotic resistance and recent antibiotics' discovery","volume":"6","author":"Chaudhary","year":"2016","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.micpath.2019.02.012_bib17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1476-5381.2011.01250.x","article-title":"Novel classes of antibiotics or more of the same?: new antibiotic classes are urgently needed","volume":"163","author":"Coates","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.micpath.2019.02.012_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12866-015-0548-8","article-title":"Serratiopeptidase: a well-known metalloprotease with a new non-proteolytic activity against S. aureus biofilm","volume":"15","author":"Selan","year":"2015","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2019.02.012_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.micpath.2013.05.003","article-title":"A new anti-infective strategy to reduce the spreading of antibiotic resistance by the action on adhesion-mediated virulence factors in Staphylococcus aureus","volume":"63","author":"Papa","year":"2013","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2019.02.012_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/039463201402700426","article-title":"Effect of betamethasone in combination with antibiotics on Gram positive and Gram negative bacteria","volume":"27","author":"Artini","year":"2014","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.micpath.2019.02.012_bib21","series-title":"Antibiot. Resist. Implic. Glob. Health Nov. Interv. Strateg. Workshop Summ.","article-title":"The case for pathogen-specific therapy","author":"Casadevall","year":"2010"},{"key":"10.1016\/j.micpath.2019.02.012_bib22","series-title":"Bioact. Heterocycles VII","first-page":"153","article-title":"Bioactive phenothiazines and benzo[a]phenothiazines: spectroscopic studies, and biological and biomedical properties and applications","author":"Aaron","year":"2008"},{"key":"10.1016\/j.micpath.2019.02.012_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.colsurfa.2014.08.023","article-title":"Surface properties of Vancomycin after interaction with laser beams","volume":"480","author":"Dinache","year":"2015","journal-title":"Colloids Surf. Physicochem. Eng. Asp."},{"key":"10.1016\/j.micpath.2019.02.012_bib24","first-page":"1291","article-title":"Rapid, laser-induced conversion of 20-hydroxyecdysone and its diacetonide -- experimental set-up of a system for photochemical transformation of bioactive substances","volume":"32","author":"Hunyadi","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.micpath.2019.02.012_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/pho.2011.3187","article-title":"Laser beams interaction with polidocanol foam: molecular background","volume":"30","author":"Smarandache","year":"2012","journal-title":"Photomed. Laser Surg."},{"key":"10.1016\/j.micpath.2019.02.012_bib26","first-page":"1942","article-title":"Measurement of the modifications of Polidocanol absorption spectra after exposure to NIR laser radiation","volume":"12","author":"Smarandache","year":"2010","journal-title":"J. Optoelectron. Adv. Mater."},{"key":"10.1016\/j.micpath.2019.02.012_bib27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/157018011794183752","article-title":"Time stability studies of quinazoline derivative designed to fight drug resistance acquired by bacteria","volume":"8","author":"Militaru","year":"2011","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.micpath.2019.02.012_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/1ba396af-ad78-4740-b9f8-93cf03661b35","article-title":"Exposure of chlorpromazine to 266 nm laser beam generates new species with antibacterial properties: contributions to development of a new process for drug discovery","volume":"8","author":"Pascu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2019.02.012_bib29","article-title":"Characterization of mixtures of compounds produced in chlorpromazine aqueous solutions by ultraviolet laser irradiation: their applications in antimicrobial assays","volume":"20","author":"Alexandru","year":"2015","journal-title":"J. Biomed. Optic."},{"key":"10.1016\/j.micpath.2019.02.012_bib30","article-title":"Biological evaluation of products formed from the irradiation of chlorpromazine with a 266 nm laser beam","volume":"02","author":"Alexandru","year":"2013","journal-title":"Biochem. Pharmacol. Open Access"},{"key":"10.1016\/j.micpath.2019.02.012_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2174\/157018012799859918","article-title":"Optical studies of the spectral properties of phenothiazines","volume":"9","author":"Smarandache","year":"2012","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.micpath.2019.02.012_bib32","first-page":"605","article-title":"The in vitro activity of products formed from exposure of chlorpromazine to a 266 nm laser beam against species of mycobacteria of human interest","volume":"27","author":"Armada","year":"2013","journal-title":"In Vivo"},{"key":"10.1016\/j.micpath.2019.02.012_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/antibiotics2010058","article-title":"Role of phenothiazines and structurally similar compounds of plant origin in the fight against infections by drug resistant bacteria","volume":"2","author":"Dastidar","year":"2013","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2019.02.012_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.colsurfb.2015.06.041","article-title":"Toxicity study in blood and tumor cells of laser produced medicines for application in fabrics","volume":"137","author":"Mor\u00e1n","year":"2016","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.micpath.2019.02.012_bib35","series-title":"Disposition of Toxic Drugs & Chemicals in Man","year":"1994"},{"key":"10.1016\/j.micpath.2019.02.012_bib36","first-page":"233","article-title":"Interaction of chlorpromazine with tricyclic anti-depressants in schizophrenic patients","volume":"44","author":"Rasheed","year":"1994","journal-title":"J. Pakistan Med. Assoc."},{"key":"10.1016\/j.micpath.2019.02.012_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.micpath.2019.02.012_bib38","article-title":"Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution","volume":"9","author":"European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)","year":"2003","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2019.02.012_bib39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/S1517-83822002000200014","article-title":"Screening for antimicrobial activity of natural products using a microplate photometer","volume":"33","author":"Devienne","year":"2002","journal-title":"Braz. J. Microbiol."},{"key":"10.1016\/j.micpath.2019.02.012_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-1110(96)90004-4","article-title":"Review of the genotoxic properties of chlorpromazine and related phenothiazines","volume":"366","author":"Gocke","year":"1996","journal-title":"Mutat. Res. Genet. Toxicol."},{"key":"10.1016\/j.micpath.2019.02.012_bib41","series-title":"Equine Infectious Diseases","year":"2007"},{"key":"10.1016\/j.micpath.2019.02.012_bib42","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.apjtm.2016.04.008","article-title":"The inhibition effect of Chlorpromazine against the b-lactam resistance of MRSA","volume":"9","author":"Kong","year":"2016","journal-title":"Asian Pac. J. Trop. Med."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018316711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018316711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T15:42:36Z","timestamp":1565192556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401018316711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":42,"alternative-id":["S0882401018316711"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2019.02.012","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antimicrobial efficacy of laser exposed chlorpromazine against Gram-positive bacteria in planktonic and biofilm growth state","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2019.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}